An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted a short plan saying they’re changing their medicines and considering adding a few experimental peptides. In plain terms: they’re lowering the dose of tirzepatide (a weekly injectable weight/diabetes drug), switching to a new weekly injection called retatrutide, continuing nightly tesamorelin for a set period, and thinking about adding two small peptides called SS-31 and MOTS-c in short cycles. It reads like a personal “stack” of drugs and research peptides aimed at weight, body composition, or metabolic health. Tirzepatide is a real prescription drug sold for diabetes and weight loss; it’s given as a weekly shot and helps control appetite and blood sugar by copying hormones your gut makes after eating. Retatrutide is a newer, experimental drug that aims to hit similar or additional targets — developers say it might produce stronger weight-loss effects, but it’s still not widely approved. Tesamorelin is an approved medicine for a specific condition (HIV-related fat redistribution) and is sometimes used off-label because it stimulates growth-hormone–releasing factors, which can change body composition. SS-31 (also called elamipretide) and MOTS-c are small lab-made peptides studied for effects on mitochondria (the cell’s energy factories); they’re mostly in early-stage research and aren’t standard clinical treatments. The “research” behind each of these things is very different. Tirzepatide has large clinical trials showing substantial weight loss and better blood sugar control when used properly. Retatrutide has promising early trial results but far fewer people studied, and it hasn’t completed the long-term safety picture yet. Tesamorelin has controlled studies for its approved use, but evidence for broader fitness or anti-aging benefits is limited. For SS-31 and MOTS-c, most evidence comes from lab studies and small human trials; results are early, mixed, and not yet definitive about benefits in healthy people. In short: some items in the stack are proven in large studies, others are speculative and mainly experimental. Why people might do this: someone chasing big changes in weight, energy, or body composition may layer medications that act on appetite, growth-hormone pathways, and cellular energy to try to get better results. For patients with obesity or diabetes, prescribed drugs like tirzepatide can be life-changing. For people curious about anti-aging or performance, the idea of adding mitochondrial-targeting peptides is attractive because they theoretically improve cellular energy. But “better” is not guaranteed, and combining multiple active drugs increases complexity. Important caveats and risks: mixing prescription drugs should be done with a doctor who knows your full medical history. Side effects vary by drug — common ones include nausea, digestive upset, injection-site reactions, and changes in blood sugar, but there can also be more serious risks. Retatrutide and peptides like SS-31 and MOTS-c are still experimental or not widely regulated; purity, dosing, and long-term safety may be unknown. Tesamorelin has approved uses but may have side effects and is not a general weight-loss pill. People who are pregnant, breastfeeding, have certain heart, liver, or endocrine conditions, or take other medications should be especially cautious. If a post doesn’t cite trials or a doctor’s guidance, treat it as anecdote, not medical advice. Bottom line: some components in this stack are well-studied, some are experimental, and combining them increases uncertainty — talk to a knowledgeable clinician and rely on established evidence before trying it.
Source: r/Peptides